Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 3,114 | 3,084 | 2,412 | 2,222 | 1,810 |
| Cost of Goods | 1,255 | 1,297 | 964 | 873 | 820 |
| Gross Profit | 1,859 | 1,787 | 1,448 | 1,349 | 991 |
| Operating Expenses | 3,671 | 6,654 | 4,556 | 4,910 | 3,900 |
| Operating Income | -1,558 | -4,570 | -2,144 | -2,687 | -2,090 |
| Other Income | 33 | -482 | -44 | -318 | 254 |
| Pre-tax Income | -1,525 | -5,052 | -2,188 | -3,005 | -1,836 |
| Net Income Continuous | -1,525 | -4,734 | -2,188 | -3,005 | -1,836 |
| Net Income | $-1,525 | $-4,734 | $-2,188 | $-3,005 | $-1,836 |
| EPS Basic Total Ops | -0.06 | -0.18 | -0.09 | -0.12 | -0.07 |
| EPS Basic Continuous Ops | -0.06 | -0.19 | -0.09 | -0.12 | -0.07 |
| EPS Diluted Total Ops | -0.06 | -0.18 | -0.09 | -0.12 | -0.07 |
| EPS Diluted Continuous Ops | -0.06 | -0.19 | -0.09 | -0.12 | -0.07 |
| EBITDA(a) | $-1,479 | $-4,503 | $-2,089 | $-2,650 | $-2,058 |